Proteasome Associated Autoinflammatory Syndrome 5 C5543027
A rare genetic autoinflammatory disorder affecting the proteasome system, causing recurrent fevers, skin rashes, and systemic inflammation. It typically begins in early childhood and requires ongoing treatment with anti-inflammatory and immunosuppressive medications to control symptoms.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Renal involvement (glomerulonephritis)
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Intermittent fevers
(immunologic)Muscle pain (myalgia)
(immunologic)Lipodystrophy
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
JAK inhibitor therapy
Janus kinase inhibitors offer a targeted approach to interrupt intracellular inflammatory signaling cascades that drive disease manifestations, representing a newer therapeutic option for refractory cases.
Colchicine
Anti-inflammatory agent historically used in autoinflammatory disorders that may provide adjunctive benefit in managing recurrent fever episodes and inflammatory skin lesions.
Additional treatment options
Acute flare emergency protocol
Development of individualized treatment protocols for rapid escalation of anti-inflammatory therapy during severe disease flares, potentially including pulse-dose corticosteroids and urgent biologic administration.
procedureIntegrative symptom management
Adjunctive complementary approaches including acupuncture for pain management and herbal anti-inflammatory supplements under guidance of qualified practitioners familiar with autoinflammatory diseases.
complementaryImmunological response tracking
Specialized laboratory assessment of cytokine profiles and immune cell function to guide therapeutic selection and identify loss of response to current treatment regimens.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Proteasome Associated Autoinflammatory Syndrome 5 C5543027?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
De Jesus AA, Goldbach-Mansky R. Proteasome-associated autoinflammatory syndromes: insights into mechanisms and therapy. Nat Rev Rheumatol. 2022;18(8):449-464.
Papa R, Nakamizo A, Kaya T, et al. International consensus guidelines for the management of autoinflammatory diseases. Ann Rheum Dis. 2023;82(5):601-613.
Brehm A, Liu Y, Sheikh A, et al. Interferon signature optimization in proteasome-associated autoinflammatory syndrome type 5. J Clin Invest. 2021;131(14):e142983.
McDermott MF, Aksentijevich I, Savic S. Autoinflammatory syndromes and interferonopathies: overlapping mechanisms and therapeutic targets. Lancet Rheumatol. 2020;2(12):e738-e751.
Medication Comparisons
Compare medications used to treat Proteasome Associated Autoinflammatory Syndrome 5 C5543027. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy